Is MASLD an independent risk factor for micro- and macrovascular complications of diabetes? A critical reappraisal and future directions.
Fatty liver disease worsens diabetes complications through shared risk factors rather than acting alone, suggesting combined management strategies may be most effective.
MASLD functions as a risk enhancer rather than independent risk factor for diabetic micro- and macrovascular complications; most available evidence has critical limitations including inadequate control for shared cardiometabolic risk factors and heterogeneous study designs. This record was retained from the prior triage attempt for PubMed pipeline handoff.
What the study was
- Study design
- Critical systematic reappraisal with structured evidence synthesis (cross-sectional, longitudinal studies, and trial data)
- Category
- cardiovascular_metabolic
- Maturity
- Validated
- Journal
- Diabetologia
Why it surfaced
High-impact Diabetologia critical review reframing MASLD-diabetes complication relationship from leading centers; directly relevant to cardiometabolic watchlist; immediately actionable for clinical risk stratification of MASLD patients.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.